Clinical Trial Update: Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial) [Phase 3]

View source ↗

Summary

Phase 3 PET PREVENT trial evaluated PET imaging for post-radiation assessment of head and neck cancer and has completed. The snippet does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Cancer of the Head and Neck | Phase 3 | Status: COMPLETED